NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO

Position in CHRS — Coherus Oncology, Inc.

CIK 1141802 MILWAUKEE, WI

Position in CHRS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$10,290

-$2,131 QoQ

Shares Held

7,350

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#118

of 145 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO holds $32,462,816 across 144 Biotechnology names. CHRS ranks #54 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	53,309	$6,043,108
2	PTGX	Protagonist Therapeutics, Inc	48,894	$5,993,426
3	VRTX	Vertex Pharmaceuticals Inc / Ma	9,613	$4,775,065
4	REGN	Regeneron Pharmaceuticals, Inc.	5,101	$3,180,677
5	JAZZ	Jazz Pharmaceuticals plc	10,526	$2,536,450
6	BMRN	Biomarin Pharmaceutical Inc	35,863	$2,052,080
7	RPRX	Royalty Pharma plc	30,218	$1,694,323
8	MRNA	Moderna, Inc.	14,469	$1,013,264

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,290	7,350	0.0%	Shares	Defined	2026-08-12
2026-03-31	$12,421	7,350	0.0%	Shares	Defined	2026-05-07
2025-12-31	$10,437	7,350	0.0%	Shares	Defined	2026-02-10
2025-09-30	$12,054	7,350	-0.5%	Shares	Defined	2025-11-14
2025-06-30	$5,398	7,385	-25.0%	Shares	Defined	2025-08-13
2025-03-31	$7,948	9,850	+34.0%	Shares	Defined	2025-05-14
2024-12-31	$10,143	7,350	0.0%	Shares	Defined	2025-02-11
2024-09-30	$7,644	7,350	0.0%	Shares	Defined	2024-11-12
2024-06-30	$12,715	7,350	0.0%	Shares	Defined	2024-08-16
2024-03-31	$17,566	7,350	+43135.3%	Shares	Defined	2024-05-15
2021-12-31	$271	17	—	Shares	Defined	2022-02-03
No filing history on record for this holder in this stock.